Federico, A. D., Wang, K., Chen, M. F., Barsouk, A., Pagliaro, A., Chen, L. N., Ogliari, F., Stockhammer, P., Thawani, R., Raslan, S., Gariazzo, E., Fusco, F., Hambelton, G., Citarella, F., Meyer, D., Corassa, M., Langer, C. J., Offin, M., Negrao, M. V., Ricciuti, B. (2025). First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAF
            <sup>V600E</sup>
            -mutated metastatic non-small cell lung cancer: The FRONT-BRAF study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8574